<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Curr Neuropharmacol</journal-id><journal-id journal-id-type="iso-abbrev">Curr Neuropharmacol</journal-id><journal-id journal-id-type="publisher-id">CN</journal-id><journal-title-group><journal-title>Current Neuropharmacology</journal-title></journal-title-group><issn pub-type="ppub">1570-159X</issn><issn pub-type="epub">1875-6190</issn><publisher><publisher-name>Bentham Science Publishers</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24851086</article-id><article-id pub-id-type="pmc">4023452</article-id><article-id pub-id-type="publisher-id">CN-12-213</article-id><article-id pub-id-type="doi">10.2174/1570159X11666131225000518</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Protein Kinase C-Related Kinase (PKN/PRK). Potential Key-Role for
PKN1 in Protection of Hypoxic Neurons</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Thauerer</surname><given-names>Bettina</given-names></name></contrib><contrib contrib-type="author"><name><surname>zur Nedden</surname><given-names>Stephanie</given-names></name></contrib><contrib contrib-type="author"><name><surname>Baier-Bitterlich</surname><given-names>Gabriele</given-names></name><xref ref-type="corresp" rid="cor1">*</xref></contrib></contrib-group><aff>Medical University of Innsbruck, Biocenter/ Neurobiochemistry, Innrain 80-82, A-6020 Innsbruck, Austria</aff><author-notes><corresp id="cor1"><label>*</label>Address correspondence to this author at the Medical University of
Innsbruck, Biocenter /Div. of Neurobiochemistry, Innrain 80-82, A-6020
Innsbruck, Austria; Tel: 0043 512 9003 70289; Fax: 0043 512 9003 73110;
E-mail: <email xlink:href="gabriele.baier-bitterlich@i-med.ac.at">gabriele.baier-bitterlich@i-med.ac.at</email></corresp></author-notes><pub-date pub-type="ppub"><month>5</month><year>2014</year></pub-date><pub-date pub-type="epub"><month>5</month><year>2014</year></pub-date><volume>12</volume><issue>3</issue><fpage>213</fpage><lpage>218</lpage><history><date date-type="received"><day>11</day><month>7</month><year>2013</year></date><date date-type="rev-recd"><day>20</day><month>8</month><year>2013</year></date><date date-type="accepted"><day>10</day><month>12</month><year>2013</year></date></history><permissions><copyright-statement>&#x000a9;2014 Bentham Science Publishers</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Bentham Science Publishers</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p>This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (<uri xlink:type="simple" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</uri>) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.</license-p></license></permissions><abstract><p>Serine/threonine protein kinase C-related kinase (PKN/PRK) is a family of three isoenzymes (PKN1, PKN2,
PKN3), which are widely distributed in eukaryotic organisms and share the same overall domain structure. The Nterminal
region encompasses a conserved repeated domain, termed HR1a-c as well as a HR2/C2 domain. The
serine/threonine kinase domain is found in the C-terminal region of the protein and shows high sequence homology to
other members of the PKC superfamily.</p><p>
In neurons, PKN1 is the most abundant isoform and has been implicated in a variety of functions including cytoskeletal
organization and neuronal differentiation and its deregulation may contribute to neuropathological processes such as
amyotrophic lateral sclerosis and Alzheimer&#x02019;s disease. We have recently identified a candidate role of PKN1 in the
regulation of neuroprotective processes during hypoxic stress. Our key findings were that: 1) the activity of PKN1 was
significantly increased by hypoxia (1% O2) and neurotrophins (nerve growth factor and purine nucleosides); 2) Neuronal
cells, deficient of PKN1 showed a decrease of cell viability and neurite formation along with a disturbance of the F-actinassociated
cytoskeleton; 3) Purine nucleoside-mediated neuroprotection during hypoxia was severely hampered in PKN1
deficient neuronal cells, altogether suggesting a potentially critical role of PKN1 in neuroprotective processes.</p><p>
This review gives an up-to-date overview of the PKN family with a special focus on the neuroprotective role of PKN1 in
hypoxia.</p></abstract><kwd-group><title>Keywords</title><kwd>Hypoxia</kwd><kwd>neuroprotection</kwd><kwd>PKN</kwd><kwd>PRK</kwd><kwd>protein kinase C-related kinase</kwd><kwd>purine nucleosides</kwd><kwd>review.</kwd></kwd-group></article-meta></front><body><sec><title>INTRODUCTION </title><p>Protein kinase C-related kinase 1 (PKN1/PRK1) belongs to the protein kinase C (PKC)-related kinase family (PKN/PRK), a recently discovered subfamily of the AGC serine/threonine protein kinases [<xref rid="R1" ref-type="bibr">1</xref>-<xref rid="R3" ref-type="bibr">3</xref>]. PKNs are widely distributed in eukaryotic organisms, such as starfish, amphibians, insects and mammals [<xref rid="R4" ref-type="bibr">4</xref>,<xref rid="R5" ref-type="bibr"> 5</xref>]. To date three different PKN isoforms have been described: PKN1 (PKN alpha/PRK1/PAK-1), PKN2 (PKN gamma/PRK2/PAK-2) and PKN3 (PKN beta/PRK3) [<xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R6" ref-type="bibr"> 6</xref>,<xref rid="R7" ref-type="bibr"> 7</xref>]. Although PKN isoforms are intimately related they may not substitute for one another, consistent with the isoform-specific effects and varying tissue expression levels, as reviewed: [<xref rid="R8" ref-type="bibr">8</xref>]. The expression of PKN1 in human and rat tissue [<xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R9" ref-type="bibr"> 9</xref>,<xref rid="R10" ref-type="bibr"> 10</xref>] and PKN2 in mouse tissue [<xref rid="R11" ref-type="bibr">11</xref>] is rather ubiquitous. However, PKN3 expression is more restricted to specific tissues including skeletal muscle, heart, liver [<xref rid="R12" ref-type="bibr">12</xref>] and human cancer cell lines [<xref rid="R7" ref-type="bibr">7</xref>]. In neurons PKN1 is the most abundant isoform and has been implicated in a variety of functions including cytoskeletal organization and neuronal differentiation [<xref rid="R5" ref-type="bibr">5</xref>,<xref rid="R13" ref-type="bibr"> 13</xref>-<xref rid="R17" ref-type="bibr">17</xref>]. A role of PKN1 in amyotrophic lateral sclerosis (ALS) [<xref rid="R18" ref-type="bibr">18</xref>,<xref rid="R19" ref-type="bibr"> 19</xref>] and in Alzheimer&#x02019;s disease [<xref rid="R20" ref-type="bibr">20</xref>,<xref rid="R21" ref-type="bibr"> 21</xref>] has been implicated. Furthermore our own data suggested that PKN1 is a key-signaling element in purine nucleoside- and nerve growth factor (NGF)-mediated protection of hypoxic neurons [<xref rid="R22" ref-type="bibr">22</xref>,<xref rid="R23" ref-type="bibr"> 23</xref>]. </p></sec><sec><title>BASIC STRUCTURE OF PKNs</title><p>The PKN family members PKN1, PKN2, and PKN3 share the same overall domain structure. The N-terminal region encompasses a conserved repeated domain, termed HR1a-c (for homology repeat, also known as ACC1-3) as well as a HR2/C2 domain. The latter one is related to the calcium-dependent membrane-targeting domain in PKC and contains a C-terminal auto-inhibitory region (IR) [<xref rid="R24" ref-type="bibr">24</xref>]. The serine/threonine kinase domain is found in the C-terminal region of the protein and shows high sequence homology to other members of the PKC superfamily [<xref rid="R4" ref-type="bibr">4</xref>,<xref rid="R5" ref-type="bibr"> 5</xref>] (Fig. <bold><xref ref-type="fig" rid="F1">1</xref></bold>). </p></sec><sec><title>REGULATION OF PKNs</title><p>The N-terminal region plays an important role in the regulation of PKNs, for reviews see: [<xref rid="R8" ref-type="bibr">8</xref>,<xref rid="R25" ref-type="bibr"> 25</xref>,<xref rid="R26" ref-type="bibr"> 26</xref>]. The HR1 region is involved in the interaction with the small GTPases Rho and Rac [<xref rid="R2" ref-type="bibr">2</xref>,<xref rid="R4" ref-type="bibr"> 4</xref>,<xref rid="R5" ref-type="bibr"> 5</xref>,<xref rid="R25" ref-type="bibr"> 25</xref>,<xref rid="R27" ref-type="bibr"> 27</xref>-<xref rid="R36" ref-type="bibr">36</xref>]. Rho, binds to PKN and induces a conformational change that allows binding to phosphoinositide-dependent protein kinase 1(PDK1), which phosphorylates PKN in the activation loop and stimulates its protein kinase activity [<xref rid="R5" ref-type="bibr">5</xref>,<xref rid="R25" ref-type="bibr"> 25</xref>,<xref rid="R37" ref-type="bibr"> 37</xref>]. The HR2/C2-like domain, does not bind Ca<sup>2+</sup> as expected, but is potentially involved in the activation of PKNs by lipids or the targeting of PKNs to the membrane [<xref rid="R4" ref-type="bibr">4</xref>,<xref rid="R5" ref-type="bibr"> 5</xref>,<xref rid="R25" ref-type="bibr"> 25</xref>,<xref rid="R38" ref-type="bibr"> 38</xref>]. The C-terminal part of the C2-</p><p>like region functions as an arachidonic acid-sensitive auto-inhibitory region (IR) [<xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R24" ref-type="bibr"> 24</xref>,<xref rid="R25" ref-type="bibr"> 25</xref>,<xref rid="R39" ref-type="bibr"> 39</xref>-<xref rid="R42" ref-type="bibr">42</xref>]. N-terminally truncated PKNs e.g. by caspase cleavage [<xref rid="R18" ref-type="bibr">18</xref>] apparently behave as constitutively-active isoforms [<xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R6" ref-type="bibr"> 6</xref>,<xref rid="R9" ref-type="bibr"> 9</xref>,<xref rid="R25" ref-type="bibr"> 25</xref>,<xref rid="R43" ref-type="bibr"> 43</xref>-<xref rid="R46" ref-type="bibr">46</xref>]. In addition, PKNs were shown to be activated by various fatty acids and phospholipids <italic>in vitro</italic>, although the <italic>in vivo</italic> significance is as yet not fully characterized too [<xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R6" ref-type="bibr"> 6</xref>,<xref rid="R7" ref-type="bibr"> 7</xref>,<xref rid="R9" ref-type="bibr"> 9</xref>,<xref rid="R43" ref-type="bibr"> 43</xref>,<xref rid="R44" ref-type="bibr"> 44</xref>,<xref rid="R47" ref-type="bibr"> 47</xref>,<xref rid="R48" ref-type="bibr"> 48</xref>]. </p></sec><sec><title>CELLULAR PKN UPSTREAM SIGNALS</title><p>The individual PKN isoforms have been linked to selective upstream signals [<xref rid="R8" ref-type="bibr">8</xref>] and signaling modules like neurotrophins [<xref rid="R22" ref-type="bibr">22</xref>,<xref rid="R23" ref-type="bibr"> 23</xref>] and androgen receptors [<xref rid="R49" ref-type="bibr">49</xref>,<xref rid="R50" ref-type="bibr"> 50</xref>] for PKN1, Platelet-derived growth factor (PDGF) and cell surface molecule CD44 for PKN2 [<xref rid="R51" ref-type="bibr">51</xref>] and insulin for PKN3 [<xref rid="R52" ref-type="bibr">52</xref>], suggesting that each isoform is associated with different adaptor proteins [<xref rid="R11" ref-type="bibr">11</xref>,<xref rid="R53" ref-type="bibr"> 53</xref>,<xref rid="R54" ref-type="bibr"> 54</xref>]. PKNs are implicated in signal transduction as effectors of Rho, Rac, PI3K (phosphoinositide 3-kinase) and Rho-like Rho-kinase [<xref rid="R51" ref-type="bibr">51</xref>,<xref rid="R52" ref-type="bibr"> 52</xref>,<xref rid="R55" ref-type="bibr"> 55</xref>-<xref rid="R57" ref-type="bibr">57</xref>] and all three PKN isoforms can support Rho-dependent cell migration [<xref rid="R8" ref-type="bibr">8</xref>]. </p></sec><sec><title>GENERAL FUNCTION OF PKNs</title><p>As diverse as the distribution of the PKN family are its functions, which were recently reviewed [<xref rid="R26" ref-type="bibr">26</xref>], including regulation of cell cycle [<xref rid="R58" ref-type="bibr">58</xref>], receptor trafficking [<xref rid="R59" ref-type="bibr">59</xref>], vesicle transport [<xref rid="R60" ref-type="bibr">60</xref>] and apoptosis [<xref rid="R61" ref-type="bibr">61</xref>]. More than 20 proteins and several peptides were shown to be phosphorylated by PKN1 and PKN2, including the cytoskeletal proteins <italic>&#x003b1;</italic>-actinin and vimentin, as reviewed [<xref rid="R26" ref-type="bibr">26</xref>]. Recently, the same authors also showed that CLIP-170 (cytoplasmic linker protein of 170 kDa) and EGFR (epidermal growth factor receptor) are substrates for PKN1 and PKN3 [<xref rid="R26" ref-type="bibr">26</xref>]. Data by us [<xref rid="R16" ref-type="bibr">16</xref>] and others [<xref rid="R60" ref-type="bibr">60</xref>-<xref rid="R63" ref-type="bibr">63</xref>] link PKN1 to several stress induced pathways.</p><p>PKN2 is involved in actin cytoskeletal organization [<xref rid="R31" ref-type="bibr">31</xref>], mainly through activation by Rho GTPases [<xref rid="R5" ref-type="bibr">5</xref>]. PKN2 also plays a role alongside Fyn in controlling cell&#x02013;cell adhesion in keratinocytes [<xref rid="R64" ref-type="bibr">64</xref>] and the maturation of apical junctions [<xref rid="R38" ref-type="bibr">38</xref>]. In addition, PKN2 can modulate migration in astrocytes by up-regulating cortactin phosphorylation [<xref rid="R51" ref-type="bibr">51</xref>] PKN3 has been identified as an effector required for malignant cell growth, downstream of activated phosphoinositide 3-kinase (PI3K) [<xref rid="R52" ref-type="bibr">52</xref>]. More recently, it has been shown that knockdown of PKN3 can decrease the growth of prostate and pancreatic tumors, and prevent lung metastases in mouse models [<xref rid="R65" ref-type="bibr">65</xref>,<xref rid="R66" ref-type="bibr"> 66</xref>]. </p></sec><sec><title>ROLE OF PKN1 IN NEURODEGENERATIVE DISEASES</title><p>In neurons, PKN1 is the most abundant isoform and has been implicated in a variety of functions including cytoskeletal organization and neuronal differentiation [<xref rid="R5" ref-type="bibr">5</xref>,<xref rid="R13" ref-type="bibr"> 13</xref>,<xref rid="R17" ref-type="bibr"> 17</xref>]. PKN1 was shown to phosphorylate neurofilaments at sites important for neurofilament assembly [<xref rid="R14" ref-type="bibr">14</xref>,<xref rid="R15" ref-type="bibr"> 15</xref>]. Dysfunction of neurofilament metabolism was strongly implicated in amyotrophic lateral sclerosis (ALS) and in some forms of Charcot-Marie-Tooth disease [<xref rid="R18" ref-type="bibr">18</xref>,<xref rid="R19" ref-type="bibr"> 19</xref>]. In ALS, accumulating neurofilaments represent one of the earliest pathological changes seen in several transgenic mouse models of ALS [<xref rid="R67" ref-type="bibr">67</xref>-<xref rid="R69" ref-type="bibr">69</xref>]. Along this line, it was shown that caspase-mediated processing of PKN1, induced by excitotoxic glutamate release and other disease-associated insults leads to deregulation of PKN1 [<xref rid="R18" ref-type="bibr">18</xref>] and subsequently to a disruption of neurofilament organization, axonal transport mechanisms [<xref rid="R18" ref-type="bibr">18</xref>,<xref rid="R46" ref-type="bibr"> 46</xref>] and potentially also to apoptosis [<xref rid="R45" ref-type="bibr">45</xref>]. Other results [<xref rid="R20" ref-type="bibr">20</xref>,<xref rid="R21" ref-type="bibr"> 21</xref>], suggested a specific role for PKN in neurofibrillary tangle formation and neurodegeneration in damaged neurons in Alzheimer&#x02019;s disease. Authors showed that PKN phosphorylated tau protein, potentially playing an important role in the aggregation of tau into helical filaments. However, any clear evidence for the involvement of PKN1 in the pathogenesis of neurodegenerative diseases is as yet missing.</p></sec><sec><title>ROLE OF PKN1 IN HYPOXIC NEURONS</title><p>Hypoxic stress (1% O<sub>2</sub>)induces an increase in cell death of PC12 neuronal cells and primary neurons [<xref rid="R23" ref-type="bibr">23</xref>,<xref rid="R70" ref-type="bibr"> 70</xref>,<xref rid="R71" ref-type="bibr"> 71</xref>]. Targeting apoptotic processes after ischemic stroke has been a key focus of neuroprotective therapeutic interventions. Numerous authors, (see reviews [<xref rid="R72" ref-type="bibr">72</xref>-<xref rid="R74" ref-type="bibr">74</xref>]) have proposed adenosine and its receptors as targets for therapeutic approaches in stroke and related disorders. We have previously studied neuronal signaling in hypoxia and observed a protective capacity of the purine nucleosides adenosine, guanosine and inosine in both PC12 cells [<xref rid="R22" ref-type="bibr">22</xref>,<xref rid="R71" ref-type="bibr"> 71</xref>,<xref rid="R75" ref-type="bibr"> 75</xref>,<xref rid="R76" ref-type="bibr"> 76</xref>] and in primary cerebellar granule neurons [<xref rid="R71" ref-type="bibr">71</xref>,<xref rid="R77" ref-type="bibr"> 77</xref>-<xref rid="R79" ref-type="bibr">79</xref>]; see also our latest review: [<xref rid="R70" ref-type="bibr">70</xref>], which was inhibited by adenosine receptor (ADORA) antagonists, as reviewed [<xref rid="R70" ref-type="bibr">70</xref>].</p><p>Furthermore exposure of neuronal cells to low oxygen lead to increased phosphorylation of PKN1, which was augmented by NGF and purine nucleosides [<xref rid="R16" ref-type="bibr">16</xref>,<xref rid="R22" ref-type="bibr"> 22</xref>]. siRNA-mediated knockdown of PKN1 in neuronal PC12 cells leads to an increase of cell death and inhibition of neurite formation accompanied by disturbance of the F-actin-associated cytoskeleton [<xref rid="R16" ref-type="bibr">16</xref>]. These results complement a previous report [<xref rid="R80" ref-type="bibr">80</xref>], showing the binding of PKN1 to the actin bundling protein alpha-actinin in a phosphatidylinositol-4,5-bisphosphate dependent manner. </p><p>These results indicate that PKN1 may act as a key-signaling element for purine nucleoside- and potentially ADORA-associated protective mechanisms in hypoxic neuronal cells (Fig. <bold><xref ref-type="fig" rid="F2">2</xref></bold>). </p></sec><sec sec-type="conclusion"><title>CONCLUSION</title><p>In neurons, PKN1 is the most abundant isoform and has been implicated in a variety of functions including cytoskeletal organization and neuronal differentiation [<xref rid="R5" ref-type="bibr">5</xref>,<xref rid="R13" ref-type="bibr"> 13</xref>,<xref rid="R17" ref-type="bibr"> 17</xref>]. PKNs are also involved in regulation of stress response of neuronal cells as well as primary neurons and deregulation of PKN1 may contribute to neuropathological processes such as amyotrophic lateral sclerosis [<xref rid="R18" ref-type="bibr">18</xref>] and Alzheimer&#x02019;s disease [<xref rid="R20" ref-type="bibr">20</xref>,<xref rid="R21" ref-type="bibr"> 21</xref>]. </p><p>Our lab has focused on neuronal stress response during hypoxia. We observed that addition of the neurotrophins NGF and purine nucleosides (PN) resulted in significant neuroprotection [<xref rid="R16" ref-type="bibr">16</xref>,<xref rid="R71" ref-type="bibr"> 71</xref>], whereby the effect associated with PN was inhibited by adenosine receptor (ADORA) antagonists, as reviewed [<xref rid="R70" ref-type="bibr">70</xref>]. As observed in our experiments purine nucleosides as well as NGF also lead to the activation of PKN1 and to stabilization of cell viability and neurite formation, whereas knockdown of PKN1 leads to the inhibition of PKN1 and to neurodegeneration [<xref rid="R16" ref-type="bibr">16</xref>,<xref rid="R22" ref-type="bibr"> 22</xref>]. Thus, PKN1 is apparently part of a key-signaling module fostering the response to hypoxic stress and likely indispensable for neurotrophin-mediated protection of hypoxic neuronal cells [<xref rid="R16" ref-type="bibr">16</xref>,<xref rid="R22" ref-type="bibr"> 22</xref>,<xref rid="R70" ref-type="bibr"> 70</xref>]. </p></sec></body><back><ack><title>ACKNOWLEDGEMENTS</title><p>This work was supported by the Austrian Science Fund (FWF): T 421-B18, P 19578-B05 and P 26002-B24. We are grateful to Dr. C. Bandtlow and Dr. G. Baier for helpful discussions.</p></ack><sec><title>CONFLICT OF INTEREST</title><p>The authors confirm that this article content has no conflict of interest.</p></sec><sec><title>ABBREVIATIONS</title><def-list><def-item><term id="A1">ADORA </term><def><p>&#x02003;=&#x02003; adenosine receptors</p></def></def-item><def-item><term id="A2">ALS </term><def><p>&#x02003;=&#x02003; amyotrophic lateral sclerosis</p></def></def-item><def-item><term id="A3">HR </term><def><p>&#x02003;=&#x02003; homology repeat</p></def></def-item><def-item><term id="A4">NGF </term><def><p>&#x02003;=&#x02003; nerve growth factor</p></def></def-item><def-item><term id="A5">PI3K </term><def><p>&#x02003;=&#x02003; phosphoinositide 3-kinase</p></def></def-item><def-item><term id="A6">PKC </term><def><p>&#x02003;=&#x02003; protein kinase C</p></def></def-item><def-item><term id="A7">PKN1/PRK1 </term><def><p>&#x02003;=&#x02003; Protein kinase C-related kinase 1</p></def></def-item></def-list></sec><ref-list><title>REFERENCES</title><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukai</surname><given-names>H</given-names></name><name><surname>Ono</surname><given-names>Y</given-names></name></person-group><article-title>A novel protein kinase with leucine zipper-like sequences: its catalytic domain is highly homologous to that of protein kinase C.</article-title><source>Biochem. Biophys. Res. Comm</source><year>1994</year><volume>199</volume><issue>2</issue><fpage>897</fpage><lpage>904</lpage><pub-id pub-id-type="pmid">8135837</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmer</surname><given-names>RH</given-names></name><name><surname>Ridden</surname><given-names>J</given-names></name><name><surname>Parker</surname><given-names>PJ</given-names></name></person-group><article-title>Cloning and expression patterns of two members of a novel protein-kinase-C-related kinase family.</article-title><source>Eur. J. Biochem.FEBS</source><year>1995</year><volume>227</volume><issue>1-2</issue><fpage>344</fpage><lpage>51</lpage></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>SS</given-names></name><name><surname>Radzio-Andzelm</surname><given-names>E</given-names></name></person-group><article-title>Three protein kinase structures define a common motif.</article-title><source>Structure</source><year>1994</year><volume>2</volume><issue>5</issue><fpage>345</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">8081750</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mellor</surname><given-names>H</given-names></name><name><surname>Parker</surname><given-names>PJ</given-names></name></person-group><article-title>The extended protein kinase C superfamily.</article-title><source>Biochem. J</source><year>1998</year><volume>332 </volume><issue> Pt 2</issue><fpage>281</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">9601053</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukai</surname><given-names>H</given-names></name></person-group><article-title>The structure and function of PKN a protein kinase having a catalytic domain homologous to that of PKC.</article-title><source>J Biochem (Tokyo).</source><year>2003</year><volume>133</volume><issue>1</issue><fpage>17</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">12761194</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitagawa</surname><given-names>M</given-names></name><name><surname>Mukai</surname><given-names>H</given-names></name><name><surname>Shibata</surname><given-names>H</given-names></name><name><surname>Ono</surname><given-names>Y</given-names></name></person-group><article-title>Purification and characterization of a fatty acid-activated protein kinase (PKN) from rat testis.</article-title><source>Biochem. J</source><year>1995</year><volume>310 </volume><issue>Pt 2</issue><fpage>657</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">7654208</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oishi</surname><given-names>K</given-names></name><name><surname>Mukai</surname><given-names>H</given-names></name><name><surname>Shibata</surname><given-names>H</given-names></name><name><surname>Takahashi</surname><given-names>M</given-names></name><name><surname>Ona</surname><given-names>Y</given-names></name></person-group><article-title>Identification and characterization of PKNbeta a novel isoform of protein kinase PKN expression and arachidonic acid dependency are different from those of PKNalpha.</article-title><source>Biochem Biophys Res Comm.</source><year>1999</year><volume>261</volume><issue>3</issue><fpage>808</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">10441506</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lachmann</surname><given-names>S</given-names></name><name><surname>Jevons</surname><given-names>A</given-names></name><name><surname>De Rycker</surname><given-names>M</given-names></name><name><surname>Casamassima</surname><given-names>A</given-names></name><name><surname>Radtke</surname><given-names>S</given-names></name><name><surname>Collazos</surname><given-names>A</given-names></name><name><surname>Parker</surname><given-names>PJ</given-names></name></person-group><article-title>Regulatory domain selectivity in the cell-type specific PKN-dependence of cell migration.</article-title><source>PloS one.</source><year>2011</year><volume>6</volume><issue>7</issue><fpage>e21732</fpage><pub-id pub-id-type="pmid">21754995</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukai</surname><given-names>H</given-names></name><name><surname>Kitagawa</surname><given-names>M</given-names></name><name><surname>Shibata</surname><given-names>H</given-names></name><name><surname>Takanaga</surname><given-names>H</given-names></name><name><surname>Mori</surname><given-names>K</given-names></name><name><surname>Shimakawa</surname><given-names>M</given-names></name><name><surname>Miyahara</surname><given-names>M</given-names></name><name><surname>Hirao</surname><given-names>K</given-names></name><name><surname>Ono</surname><given-names>Y</given-names></name></person-group><article-title>Activation of PKN a novel 120-kDa protein kinase with leucine zipper-like sequences, by unsaturated fatty acids and by limited proteolysis.</article-title><source>Biochem. Biophys. Res. Comm</source><year>1994</year><volume>204</volume><issue>1</issue><fpage>348</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">7945381</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashimoto</surname><given-names>T</given-names></name><name><surname>Mukai</surname><given-names>H</given-names></name><name><surname>Kawamata</surname><given-names>T</given-names></name><name><surname>Taniguchi</surname><given-names>T</given-names></name><name><surname>Ono</surname><given-names>Y</given-names></name><name><surname>Tanaka</surname><given-names>C</given-names></name></person-group><article-title>Localization of PKN mRNA in the rat brain.</article-title><source>Brain Res. Mol Brain Res.</source><year>1998</year><volume>59</volume><issue>2</issue><fpage>143</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">9729343</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quilliam</surname><given-names>LA</given-names></name><name><surname>Lambert</surname><given-names>QT</given-names></name><name><surname>Mickelson-Young</surname><given-names>LA</given-names></name><name><surname>Westwick</surname><given-names>JK</given-names></name><name><surname>Sparks</surname><given-names>AB</given-names></name><name><surname>Kay</surname><given-names>BK</given-names></name><name><surname>Jenkins</surname><given-names>NA</given-names></name><name><surname>Gilbert</surname><given-names>DJ</given-names></name><name><surname>Copeland</surname><given-names>NG</given-names></name><name><surname>Der</surname><given-names>CJ</given-names></name></person-group><article-title>Isolation of a NCK-associated kinase PRK2 an SH3-binding protein and potential effector of 
Rho protein signaling.</article-title><source>J. Biol Chem.</source><year>1996</year><volume>271</volume><issue>46</issue><fpage>28772</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">8910519</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmer</surname><given-names>RH</given-names></name><name><surname>Dekker</surname><given-names>LV</given-names></name><name><surname>Woscholski</surname><given-names>R</given-names></name><name><surname>Le Good</surname><given-names>JA</given-names></name><name><surname>Gigg</surname><given-names>R</given-names></name><name><surname>Parker</surname><given-names>PJ</given-names></name></person-group><article-title>Activation of PRK1 by phosphatidylinositol 4,5-bisphosphate and phosphatidylinositol 3,4,5-trisphosphate.A comparison with protein kinase C isotypes. </article-title><source>J. Biol. Chem</source><year>1995</year><volume>270</volume><issue>38</issue><fpage>22412</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">7673228</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gudi</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>JC</given-names></name><name><surname>Casteel</surname><given-names>DE</given-names></name><name><surname>Seasholtz</surname><given-names>TM</given-names></name><name><surname>Boss</surname><given-names>GR</given-names></name><name><surname>Pilz</surname><given-names>RB</given-names></name></person-group><article-title>cGMP-dependent protein kinase inhibits serum-response element-dependent transcription by inhibiting rho activation and functions.</article-title><source>J. Biol. hem.</source><year>2002</year><volume>277</volume><issue>40</issue><fpage>37382</fpage><lpage>93</lpage></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukai</surname><given-names>H</given-names></name><name><surname>Miyahara</surname><given-names>M</given-names></name><name><surname>Sunakawa</surname><given-names>H</given-names></name><name><surname>Shibata</surname><given-names>H</given-names></name><name><surname>Toshimori</surname><given-names>M</given-names></name><name><surname>Kitagawa</surname><given-names>M</given-names></name><name><surname>Shimakawa</surname><given-names>M</given-names></name><name><surname>Takanaga</surname><given-names>H</given-names></name><name><surname>Ono</surname><given-names>Y</given-names></name></person-group><article-title>Translocation of PKN from the cytosol to the nucleus induced by stresses.</article-title><source>Proc. Natl. Acad. Sci. U. S.A</source><year>1996</year><volume>93</volume><issue>19</issue><fpage>10195</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">8816775</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sihag</surname><given-names>RK</given-names></name><name><surname>Inagaki</surname><given-names>M</given-names></name><name><surname>Yamaguchi</surname><given-names>T</given-names></name><name><surname>Shea</surname><given-names>TB</given-names></name><name><surname>Pant</surname><given-names>HC</given-names></name></person-group><article-title>Role of phosphorylation on the structural dynamics and function of types III and IV intermediate filaments.</article-title><source>Exp. Cell Res</source><year>2007</year><volume>313</volume><issue>10</issue><fpage>2098</fpage><lpage>109</lpage><pub-id pub-id-type="pmid">17498690</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thauerer</surname><given-names>B</given-names></name><name><surname>zur Nedden</surname><given-names>S</given-names></name><name><surname>Baier-Bitterlich</surname><given-names>G</given-names></name></person-group><article-title>Vital role of protein kinase C-related kinase in the formation and stability of neurites during hypoxia.</article-title><source>J. Neurochem</source><year>2010</year><volume>113</volume><issue>2</issue><fpage>432</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">20132472</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volonte</surname><given-names>C</given-names></name><name><surname>Greene</surname><given-names>LA</given-names></name></person-group><article-title>Nerve growth factor-activated protein kinase N.Characterization and rapid near homogeneity purification by nucleotide affinity-exchange chromatography.</article-title><source> J. Biol. Chem</source><year>1992</year><volume>267</volume><issue>30</issue><fpage>21663</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">1400478</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manser</surname><given-names>C</given-names></name><name><surname>Stevenson</surname><given-names>A</given-names></name><name><surname>Banner</surname><given-names>S</given-names></name><name><surname>Davies</surname><given-names>J</given-names></name><name><surname>Tudor</surname><given-names>EL</given-names></name><name><surname>Ono</surname><given-names>Y</given-names></name><name><surname>Leigh</surname><given-names>PN</given-names></name><name><surname>McLoughlin</surname><given-names>DM</given-names></name><name><surname>Shaw</surname><given-names>CE</given-names></name><name><surname>Miller</surname><given-names>CC</given-names></name></person-group><article-title>Deregulation of PKN1 activity disrupts neurofilament organisation and axonal transport.</article-title><source>FEBS Lett.</source><year>2008</year><volume>582</volume><issue>15</issue><fpage>2303</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">18519042</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>S</given-names></name><name><surname>McLean</surname><given-names>J</given-names></name><name><surname>Robertson</surname><given-names>J</given-names></name></person-group><article-title>Neuronal intermediate filaments and ALS: a new look at an old question.</article-title><source>Biochim. et Biophys. Act</source><year>2006</year><volume>1762</volume><issue>11-12</issue><fpage>1001</fpage><lpage>12</lpage></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawamata</surname><given-names>T</given-names></name><name><surname>Taniguchi</surname><given-names>T</given-names></name><name><surname>Mukai</surname><given-names>H</given-names></name><name><surname>Kitagawa</surname><given-names>M</given-names></name><name><surname>Hashimoto</surname><given-names>T</given-names></name><name><surname>Maeda</surname><given-names>K</given-names></name><name><surname>Ono</surname><given-names>Y</given-names></name><name><surname>Tanaka</surname><given-names>C</given-names></name></person-group><article-title>A protein kinase PKN accumulates in Alzheimer neurofibrillary tangles and associated endoplasmic reticulum-derived vesicles and phosphorylates tau protein.</article-title><source>J Neurosci.</source><year>1998</year><volume>18</volume><issue>18</issue><fpage>7402</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">9736660</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taniguchi</surname><given-names>T</given-names></name><name><surname>Kawamata</surname><given-names>T</given-names></name><name><surname>Mukai</surname><given-names>H</given-names></name><name><surname>Hasegawa</surname><given-names>H</given-names></name><name><surname>Isagawa</surname><given-names>T</given-names></name><name><surname>Yasuda</surname><given-names>M</given-names></name><name><surname>Hashimoto</surname><given-names>T</given-names></name><name><surname>Terashima</surname><given-names>A</given-names></name><name><surname>Nakai</surname><given-names>M</given-names></name><name><surname>Mori</surname><given-names>H</given-names></name><name><surname>Ono</surname><given-names>Y</given-names></name><name><surname>Tanaka</surname><given-names>C</given-names></name></person-group><article-title>Phosphorylation of tau is regulated by PKN.</article-title><source>J. Biol Chem.</source><year>2001</year><volume>276</volume><issue>13</issue><fpage>10025</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">11104762</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomaselli</surname><given-names>B</given-names></name><name><surname>Podhraski</surname><given-names>V</given-names></name><name><surname>B&#x000f6;ck</surname><given-names>G</given-names></name><name><surname>Baier-Bitterlich</surname><given-names>G</given-names></name></person-group><article-title>Early cellular responses of purine nucleoside-mediated protection of hypoxia-induced injuries of neuronal PC12 cells.</article-title><source>Am. J Biochem Biotechnol.</source><year>2005</year><volume>2</volume><issue>3</issue><fpage>161</fpage><lpage>167</lpage></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thauerer</surname><given-names>B</given-names></name><name><surname>zur Nedden</surname><given-names>S</given-names></name><name><surname>Baier-Bitterlich</surname><given-names>G</given-names></name></person-group><article-title>Vital role of protein kinase C-related kinase in the formation and stability of neurites during hypoxia.</article-title><source>J. Neurochem</source><year>2010</year><volume>113</volume><issue>2</issue><fpage>432</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">20132472</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshinaga</surname><given-names>C</given-names></name><name><surname>Mukai</surname><given-names>H</given-names></name><name><surname>Toshimori</surname><given-names>M</given-names></name><name><surname>Miyamoto</surname><given-names>M</given-names></name><name><surname>Ono</surname><given-names>Y</given-names></name></person-group><article-title>Mutational analysis of the regulatory mechanism of PKN: the regulatory region of PKN contains an arachidonic acid-sensitive autoinhibitory domain.</article-title><source>J. Biochem</source><year>1999</year><volume>126</volume><issue>3</issue><fpage>475</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">10467162</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bauer</surname><given-names>AF</given-names></name><name><surname>Sonzogni</surname><given-names>S</given-names></name><name><surname>Meyer</surname><given-names>L</given-names></name><name><surname>Zeuzem</surname><given-names>S</given-names></name><name><surname>Piiper</surname><given-names>A</given-names></name><name><surname>Biondi</surname><given-names>RM</given-names></name><name><surname>Neimanis</surname><given-names>S</given-names></name></person-group><article-title>Regulation of protein kinase C-related protein kinase 2 (PRK2): by an intermolecular PRK2-PRK2 interaction mediated by Its N-terminal domain.</article-title><source>J. Biol. Chem</source><year>2012</year><volume>287</volume><issue>24</issue><fpage>20590</fpage><lpage>602</lpage><pub-id pub-id-type="pmid">22511787</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collazos</surname><given-names>A</given-names></name><name><surname>Michael</surname><given-names>N</given-names></name><name><surname>Whelan</surname><given-names>RD</given-names></name><name><surname>Kelly</surname><given-names>G</given-names></name><name><surname>Mellor</surname><given-names>H</given-names></name><name><surname>Pang</surname><given-names>LC</given-names></name><name><surname>Totty</surname><given-names>N</given-names></name><name><surname>Parker</surname><given-names>PJ</given-names></name></person-group><article-title>Site recognition and substrate screens for PKN family proteins.</article-title><source>Biochem. J</source><year>2011</year><volume>438</volume><issue>3</issue><fpage>535</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">21749319</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maesaki</surname><given-names>R</given-names></name><name><surname>Ihara</surname><given-names>K</given-names></name><name><surname>Shimizu</surname><given-names>T</given-names></name><name><surname>Kuroda</surname><given-names>S</given-names></name><name><surname>Kaibuchi</surname><given-names>K</given-names></name><name><surname>Hakoshima</surname><given-names>T</given-names></name></person-group><article-title>The structural basis of Rho effector recognition revealed by the crystal structure of human RhoA complexed with the effector domain of PKN/PRK1.</article-title><source>Mol. Cell</source><year>1999</year><volume>4</volume><issue>5</issue><fpage>793</fpage><lpage>803</lpage><pub-id pub-id-type="pmid">10619026</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amano</surname><given-names>M</given-names></name><name><surname>Chihara</surname><given-names>K</given-names></name><name><surname>Nakamura</surname><given-names>N</given-names></name><name><surname>Kaneko</surname><given-names>T</given-names></name><name><surname>Matsuura</surname><given-names>Y</given-names></name><name><surname>Kaibuchi</surname><given-names>K</given-names></name></person-group><article-title>Identification of a putative target for Rho as the serine-threonine kinase protein kinase N.</article-title><source>Science</source><year>1996</year><volume>271</volume><issue>5249</issue><fpage>648</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">8571127</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>G</given-names></name><name><surname>Saito</surname><given-names>Y</given-names></name><name><surname>Madaule</surname><given-names>P</given-names></name><name><surname>Ishizaki</surname><given-names>T</given-names></name><name><surname>Fujisawa</surname><given-names>K</given-names></name><name><surname>Morii</surname><given-names>N</given-names></name><name><surname>Mukai</surname><given-names>H</given-names></name><name><surname>Ono</surname><given-names>Y</given-names></name><name><surname>Kakizuka</surname><given-names>A</given-names></name><name><surname>Narumiya</surname><given-names>S</given-names></name></person-group><article-title>Protein kinase N (PKN): and PKN-related protein rhophilin as targets of small GTPase Rho.</article-title><source>Science.</source><year>1996</year><volume>271</volume><issue>5249</issue><fpage>645</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">8571126</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flynn</surname><given-names>P</given-names></name><name><surname>Mellor</surname><given-names>H</given-names></name><name><surname>Palmer</surname><given-names>R</given-names></name><name><surname>Panayotou</surname><given-names>G</given-names></name><name><surname>Parker</surname><given-names>PJ</given-names></name></person-group><article-title>Multiple interactions of PRK1 with RhoA Functional assignment of the Hr1 repeat motif.</article-title><source>J. Biol Chem.</source><year>1998</year><volume>273</volume><issue>5</issue><fpage>2698</fpage><lpage>705</lpage><pub-id pub-id-type="pmid">9446575</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vincent</surname><given-names>S</given-names></name><name><surname>Settleman</surname><given-names>J</given-names></name></person-group><article-title>The PRK2 kinase is a potential effector target of both Rho and Rac GTPases and regulates actin cytoskeletal organization.</article-title><source>Mol Cell Biol.</source><year>1997</year><volume>17</volume><issue>4</issue><fpage>2247</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">9121475</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Settleman</surname><given-names>J</given-names></name></person-group><article-title>The Drosophila Pkn protein kinase is a Rho/Rac effector target required for dorsal closure during embryogenesis.</article-title><source>Genes Dev.</source><year>1999</year><volume>13</volume><issue>9</issue><fpage>1168</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">10323867</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Modha</surname><given-names>R</given-names></name><name><surname>Campbell</surname><given-names>LJ</given-names></name><name><surname>Nietlispach</surname><given-names>D</given-names></name><name><surname>Buhecha</surname><given-names>HR</given-names></name><name><surname>Owen</surname><given-names>D</given-names></name><name><surname>Mott</surname><given-names>HR</given-names></name></person-group><article-title>The Rac1 polybasic region is required for interaction with its effector PRK1.</article-title><source>J Biol Chem.</source><year>2008</year><volume>283</volume><issue>3</issue><fpage>1492</fpage><lpage>500</lpage><pub-id pub-id-type="pmid">18006505</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Unsal-Kacmaz</surname><given-names>K</given-names></name><name><surname>Ragunathan</surname><given-names>S</given-names></name><name><surname>Rosfjord</surname><given-names>E</given-names></name><name><surname>Dann</surname><given-names>S</given-names></name><name><surname>Upeslacis</surname><given-names>E</given-names></name><name><surname>Grillo</surname><given-names>M</given-names></name><name><surname>Hernandez</surname><given-names>R</given-names></name><name><surname>Mack</surname><given-names>F</given-names></name><name><surname>Klippel</surname><given-names>A</given-names></name></person-group><article-title>The interaction of PKN3 with RhoC promotes malignant growth.</article-title><source>Mol. Oncol.</source><year>2012</year><volume>6</volume><issue>3</issue><fpage>284</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">22217540</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blumenstein</surname><given-names>L</given-names></name><name><surname>Ahmadian</surname><given-names>MR</given-names></name></person-group><article-title>Models of the cooperative mechanism for Rho effector recognition implications for RhoA-mediated effector activation.</article-title><source>J Biol Chem.</source><year>2004</year><volume>279</volume><issue>51</issue><fpage>53419</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">15475352</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Owen</surname><given-names>D</given-names></name><name><surname>Lowe</surname><given-names>PN</given-names></name><name><surname>Nietlispach</surname><given-names>D</given-names></name><name><surname>Brosnan</surname><given-names>CE</given-names></name><name><surname>Chirgadze</surname><given-names>DY</given-names></name><name><surname>Parker</surname><given-names>PJ</given-names></name><name><surname>Blundell</surname><given-names>TL</given-names></name><name><surname>Mott</surname><given-names>HR</given-names></name></person-group><article-title>Molecular dissection of the interaction between the small G proteins Rac1 and RhoA and protein kinase C-related kinase 1 (PRK1).</article-title><source>J. Biol. Chem</source><year>2003</year><volume>278</volume><issue>50</issue><fpage>50578</fpage><lpage>87</lpage><pub-id pub-id-type="pmid">14514689</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flynn</surname><given-names>P</given-names></name><name><surname>Mellor</surname><given-names>H</given-names></name><name><surname>Palmer</surname><given-names>R</given-names></name><name><surname>Panayotou</surname><given-names>G</given-names></name><name><surname>Parker</surname><given-names>PJ</given-names></name></person-group><article-title>Rho GTPase control of protein kinase C-related protein kinase activation by 3-phosphoinositide dependent protein kinase.</article-title><source>J. Biol Chem.</source><year>2000</year><volume>275</volume><issue>15</issue><fpage>11064</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">10753910</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallace</surname><given-names>SW</given-names></name><name><surname>Magalhaes</surname><given-names>A</given-names></name><name><surname>Hall</surname><given-names>A</given-names></name></person-group><article-title>The Rho target PRK2 regulates apical junction formation in human bronchial epithelial cells.</article-title><source>Mol. Cell Biol.</source><year>2011</year><volume>31</volume><issue>1</issue><fpage>81</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">20974804</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gabrielli</surname><given-names>B</given-names></name><name><surname>Wettenhall</surname><given-names>RE</given-names></name><name><surname>Kemp</surname><given-names>BE</given-names></name><name><surname>Quinn</surname><given-names>M</given-names></name><name><surname>Bizonova</surname><given-names>L</given-names></name></person-group><article-title>Phosphorylation of ribosomal protein S6 and a peptide analogue of S6 by a protease-activated kinase isolated from rat liver.</article-title><source>FEBS Lett.</source><year>1984</year><volume>175</volume><issue>2</issue><fpage>219</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">6479343</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shiga</surname><given-names>K</given-names></name><name><surname>Takayama K.</surname><given-names>Futaki S</given-names></name><name><surname>Hutti J.E.</surname><given-names>Cantley LC</given-names></name><name><surname>Ueki</surname><given-names>K</given-names></name><name><surname>Ono</surname><given-names>Y</given-names></name><name><surname>Mukai</surname><given-names>H</given-names></name></person-group><article-title>Development of an intracellularly acting inhibitory peptide selective for PKN.</article-title><source>Biochem. J</source><year>2010</year><volume>425</volume><issue>2</issue><fpage>445</fpage><lpage>543</lpage><pub-id pub-id-type="pmid">19857203</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shibata</surname><given-names>H</given-names></name><name><surname>Oishi</surname><given-names>K</given-names></name><name><surname>Yamagiwa</surname><given-names>A</given-names></name><name><surname>Matsumoto</surname><given-names>M</given-names></name><name><surname>Mukai</surname><given-names>H</given-names></name><name><surname>Ono</surname><given-names>Y</given-names></name></person-group><article-title>Characterization of the interaction between RhoA and the amino-terminal region of PKN.</article-title><source>FEBS Lett.</source><year>1996</year><volume>385</volume><issue>3</issue><fpage>221</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">8647255</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitagawa</surname><given-names>M</given-names></name><name><surname>Shibata</surname><given-names>H</given-names></name><name><surname>Toshimori</surname><given-names>M</given-names></name><name><surname>Mukai</surname><given-names>H</given-names></name><name><surname>Ono</surname><given-names>Y</given-names></name></person-group><article-title>The role of the unique motifs in the amino-terminal region of PKN on its enzymatic activity.</article-title><source>Biochem. Biophys Res Comm.</source><year>1996</year><volume>220</volume><issue>3</issue><fpage>963</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">8607876</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morrice</surname><given-names>NA</given-names></name><name><surname>Fecondo</surname><given-names>J</given-names></name><name><surname>Wettenhall</surname><given-names>RE</given-names></name></person-group><article-title>Differential effects of fatty acid and phospholipid activators on the catalytic activities of a structurally novel protein kinase from rat liver.</article-title><source>FEBS Lett.</source><year>1994</year><volume>351</volume><issue>2</issue><fpage>171</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">8082759</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmer</surname><given-names>RH</given-names></name><name><surname>Parker</surname><given-names>PJ</given-names></name></person-group><article-title>Expression purification and characterization of the ubiquitous protein kinase C-related kinase 1.</article-title><source>Biochem J.</source><year>1995</year><volume>309 </volume><issue>Pt 1</issue><fpage>315</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">7619073</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>M</given-names></name><name><surname>Mukai</surname><given-names>H</given-names></name><name><surname>Toshimori</surname><given-names>M</given-names></name><name><surname>Miyamoto</surname><given-names>M</given-names></name><name><surname>Ono</surname><given-names>Y</given-names></name></person-group><article-title>Proteolytic activation of PKN by caspase-3 or related protease during apoptosis.</article-title><source>Proc. Natl. Acad. Sci. U.S.A.</source><year>1998</year><volume>95</volume><issue>20</issue><fpage>11566</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">9751706</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ueyama</surname><given-names>T</given-names></name><name><surname>Ren</surname><given-names>Y</given-names></name><name><surname>Sakai</surname><given-names>N</given-names></name><name><surname>Takahashi</surname><given-names>M</given-names></name><name><surname>Ono</surname><given-names>Y</given-names></name><name><surname>Kondoh</surname><given-names>T</given-names></name><name><surname>Tamaki</surname><given-names>N</given-names></name><name><surname>Saito</surname><given-names>N</given-names></name></person-group><article-title>Generation of a constitutively active fragment of PKN in microglia/macrophages after middle cerebral artery occlusion in rats.</article-title><source>J. Neurochem.</source><year>2001</year><volume>79</volume><issue>4</issue><fpage>903</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">11723183</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>WG</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>CH</given-names></name><name><surname>Tan</surname><given-names>BJ</given-names></name><name><surname>Armstrong</surname><given-names>JS</given-names></name><name><surname>Dokland</surname><given-names>T</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Zhu</surname><given-names>YZ</given-names></name><name><surname>Teo</surname><given-names>TS</given-names></name><name><surname>Duan</surname><given-names>W</given-names></name></person-group><article-title>The last five amino acid residues at the C-terminus of PRK1/PKN is essential for full lipid responsiveness.</article-title><source>Cell Signal.</source><year>2005</year><volume>17</volume><issue>9</issue><fpage>1084</fpage><lpage>97</lpage><pub-id pub-id-type="pmid">15993750</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Morrice</surname><given-names>NA</given-names></name><name><surname>Wettenhall</surname><given-names>RE</given-names></name></person-group><article-title>Isolation and characterization of a structural homologue of human PRK2 from rat liver.Distinguishing substrate and lipid activator specificities.</article-title><source> J Biol Chem.</source><year>1997</year><volume>272</volume><issue>15</issue><fpage>10030</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">9092545</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metzger</surname><given-names>E</given-names></name><name><surname>Muller</surname><given-names>JM</given-names></name><name><surname>Ferrari</surname><given-names>S</given-names></name><name><surname>Buettner</surname><given-names>R</given-names></name><name><surname>Schule</surname><given-names>R</given-names></name></person-group><article-title>A novel inducible transactivation domain in the androgen receptor implications for PRK in prostate cancer.</article-title><source>EMBO J.</source><year>2003</year><volume>22</volume><issue>2</issue><fpage>270</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">12514133</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metzger</surname><given-names>E</given-names></name><name><surname>Yin</surname><given-names>N</given-names></name><name><surname>Wissmann</surname><given-names>M</given-names></name><name><surname>Kunowska</surname><given-names>N</given-names></name><name><surname>Fischer</surname><given-names>K</given-names></name><name><surname>Friedrichs</surname><given-names>N</given-names></name><name><surname>Patnaik</surname><given-names>D</given-names></name><name><surname>Higgins</surname><given-names>JM</given-names></name><name><surname>Potier</surname><given-names>N</given-names></name><name><surname>Scheidtmann</surname><given-names>KH</given-names></name><name><surname>Buettner</surname><given-names>R</given-names></name><name><surname>Schule</surname><given-names>R</given-names></name></person-group><article-title>Phosphorylation of histone H3 at threonine 11 establishes a novel chromatin mark for transcriptional regulation.</article-title><source>Nat. Cell Biol</source><year>2008</year><volume>10</volume><issue>1</issue><fpage>53</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">18066052</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bourguignon</surname><given-names>LY</given-names></name><name><surname>Gilad</surname><given-names>E</given-names></name><name><surname>Peyrollier</surname><given-names>K</given-names></name><name><surname>Brightman</surname><given-names>A</given-names></name><name><surname>Swanson</surname><given-names>RA</given-names></name></person-group><article-title>Hyaluronan-CD44 interaction stimulates Rac1 signaling and PKN gamma kinase activation leading to cytoskeleton function and cell migration in astrocytes.</article-title><source>J. Neurochem.</source><year>2007</year><volume>101</volume><issue>4</issue><fpage>1002</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">17403031</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leenders</surname><given-names>F</given-names></name><name><surname>Mopert</surname><given-names>K</given-names></name><name><surname>Schmiedeknecht</surname><given-names>A</given-names></name><name><surname>Santel</surname><given-names>A</given-names></name><name><surname>Czauderna</surname><given-names>F</given-names></name><name><surname>Aleku</surname><given-names>M</given-names></name><name><surname>Penschuck</surname><given-names>S</given-names></name><name><surname>Dames</surname><given-names>S</given-names></name><name><surname>Sternberger</surname><given-names>M</given-names></name><name><surname>Rohl</surname><given-names>T</given-names></name><name><surname>Wellmann</surname><given-names>A</given-names></name><name><surname>Arnold</surname><given-names>W</given-names></name><name><surname>Giese</surname><given-names>K</given-names></name><name><surname>Kaufmann</surname><given-names>J</given-names></name><name><surname>Klippel</surname><given-names>A</given-names></name></person-group><article-title>PKN3 is required for malignant prostate cell growth downstream of activated PI 3-kinase.</article-title><source>EMBO J.</source><year>2004</year><volume>23</volume><issue>16</issue><fpage>3303</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">15282551</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gotoh</surname><given-names>Y</given-names></name><name><surname>Oishi</surname><given-names>K</given-names></name><name><surname>Shibata</surname><given-names>H</given-names></name><name><surname>Yamagiwa</surname><given-names>A</given-names></name><name><surname>Isagawa</surname><given-names>T</given-names></name><name><surname>Nishimura</surname><given-names>T</given-names></name><name><surname>Goyama</surname><given-names>E</given-names></name><name><surname>Takahashi</surname><given-names>M</given-names></name><name><surname>Mukai</surname><given-names>H</given-names></name><name><surname>Ono</surname><given-names>Y</given-names></name></person-group><article-title>Protein kinase PKN1 associates with TRAF2 and is involved in TRAF2-NF-kappaB signaling pathway.</article-title><source>Biochem. Biophys. Res. Comm</source><year>2004</year><volume>314</volume><issue>3</issue><fpage>688</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">14741690</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shibata</surname><given-names>H</given-names></name><name><surname>Oishi</surname><given-names>K</given-names></name><name><surname>Yamagiwa</surname><given-names>A</given-names></name><name><surname>Matsumoto</surname><given-names>M</given-names></name><name><surname>Mukai</surname><given-names>H</given-names></name><name><surname>Ono</surname><given-names>Y</given-names></name></person-group><article-title>PKNbeta interacts with the SH3 domains of Graf and a novel Graf related protein Graf2 which are GTPase activating proteins for Rho family.</article-title><source>J. Biochem.</source><year>2001</year><volume>130</volume><issue>1</issue><fpage>23</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">11432776</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Stolz D.B.</surname><given-names>Guo F</given-names></name><name><surname>Ross M.A.</surname><given-names>Watkins SC</given-names></name><name><surname>Tan B.J.</surname><given-names>Qi RZ</given-names></name><name><surname>Manser E.</surname><given-names>Li QT</given-names></name><name><surname>Bay B.H.</surname><given-names>Teo TS</given-names></name><name><surname>Duan</surname><given-names>W</given-names></name></person-group><article-title>Signaling via a novel integral plasma membrane pool of a serine/threonine protein kinase PRK1 in mammalian cells.</article-title><source>FASEB J.</source><year>2004</year><volume>18</volume><issue>14</issue><fpage>1722</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">15375078</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amano</surname><given-names>M</given-names></name><name><surname>Mukai</surname><given-names>H</given-names></name><name><surname>Ono</surname><given-names>Y</given-names></name><name><surname>Chihara</surname><given-names>K</given-names></name><name><surname>Matsui</surname><given-names>T</given-names></name><name><surname>Hamajima</surname><given-names>Y</given-names></name><name><surname>Okawa</surname><given-names>K</given-names></name><name><surname>Iwamatsu</surname><given-names>A</given-names></name><name><surname>Kaibuchi</surname><given-names>K</given-names></name></person-group><article-title>Identification of a putative target for Rho as the serine-threonine kinase protein kinase N.</article-title><source>Science</source><year>1996</year><volume>271</volume><fpage>648</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">8571127</pub-id></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>SP</given-names></name><name><surname>Reddy</surname><given-names>H</given-names></name><name><surname>Caivano</surname><given-names>M</given-names></name><name><surname>Cohen</surname><given-names>P</given-names></name></person-group><article-title>Specificity 
and mechanism of action of some commonly used protein 
kinase inhibitors.</article-title><source>Biochem. J</source><year>2000</year><volume>351</volume><issue>Pt 1</issue><fpage>95</fpage><lpage>105</lpage><pub-id pub-id-type="pmid">10998351</pub-id></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>A</given-names></name><name><surname>Durgan</surname><given-names>J</given-names></name><name><surname>Magalhaes</surname><given-names>A</given-names></name><name><surname>Hall</surname><given-names>A</given-names></name></person-group><article-title>Rho GTPases regulate PRK2/PKN2 to control entry into mitosis and exit from cytokinesis.</article-title><source>EMBO J</source><year>2007</year><volume>26</volume><fpage>1624</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">17332740</pub-id></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gampel</surname><given-names>A</given-names></name><name><surname>Parker</surname><given-names>PJ</given-names></name><name><surname>Mellor</surname><given-names>H</given-names></name></person-group><article-title>Regulation of epidermal growth factor receptor traffic by the small GTPase rhoB.</article-title><source>Curr. Biol</source><year>1999</year><volume>9</volume><issue>17</issue><fpage>955</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">10508588</pub-id></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torbett</surname><given-names>NE</given-names></name><name><surname>Casamassima</surname><given-names>A</given-names></name><name><surname>Parker</surname><given-names>PJ</given-names></name></person-group><article-title>Hyperosmotic-induced protein kinase N 1 activation in a vesicular compartment is dependent upon Rac1 and 3-phosphoinositide-dependent kinase 1.</article-title><source>J. Biol. Chem</source><year>2003</year><volume>278</volume><issue>34</issue><fpage>32344</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">12783890</pub-id></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takagi</surname><given-names>H</given-names></name><name><surname>Hsu</surname><given-names>CP</given-names></name><name><surname>Kajimoto</surname><given-names>K</given-names></name><name><surname>Shao</surname><given-names>D</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Maejima</surname><given-names>Y</given-names></name><name><surname>Zhai</surname><given-names>P</given-names></name><name><surname>Yehia</surname><given-names>G</given-names></name><name><surname>Yamada</surname><given-names>C</given-names></name><name><surname>Zablocki</surname><given-names>D</given-names></name><name><surname>Sadoshima</surname><given-names>J</given-names></name></person-group><article-title>Activation of PKN mediates survival of cardiac myocytes in the heart during ischemia/reperfusion.</article-title><source>Circulation Res</source><year>2010</year><volume>107</volume><issue>5</issue><fpage>642</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">20595653</pub-id></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kajimoto</surname><given-names>K</given-names></name><name><surname>Shao</surname><given-names>D</given-names></name><name><surname>Takagi</surname><given-names>H</given-names></name><name><surname>Maceri</surname><given-names>G</given-names></name><name><surname>Zablocki</surname><given-names>D</given-names></name><name><surname>Mukai</surname><given-names>H</given-names></name><name><surname>Ono</surname><given-names>Y</given-names></name><name><surname>Sadoshima</surname><given-names>J</given-names></name></person-group><article-title>Hypotonic swelling-induced activation of PKN1 mediates cell survival in cardiac myocytes.American journal of physiology. </article-title><source>Heart Circulatory Physiol</source><year>2011</year><volume>300</volume><issue>1</issue><fpage>H191</fpage><lpage>200</lpage></element-citation></ref><ref id="R63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marinissen</surname><given-names>MJ</given-names></name><name><surname>Chiariello</surname><given-names>M</given-names></name><name><surname>Gutkind</surname><given-names>JS</given-names></name></person-group><article-title>Regulation of gene expression by the small GTPase Rho through the ERK6 (p38 gamma): MAP kinase pathway.</article-title><source>Genes Dev</source><year>2001</year><volume>15</volume><issue>5</issue><fpage>535</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">11238375</pub-id></element-citation></ref><ref id="R64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calautti</surname><given-names>E</given-names></name><name><surname>Grossi</surname><given-names>M</given-names></name><name><surname>Mammucari</surname><given-names>C</given-names></name><name><surname>Aoyama</surname><given-names>Y</given-names></name><name><surname>Pirro</surname><given-names>M</given-names></name><name><surname>Ono</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Dotto</surname><given-names>GP</given-names></name></person-group><article-title>Fyn tyrosine kinase is a downstream mediator of Rho/PRK2 function in keratinocyte cell-cell adhesion.</article-title><source>J Cell Biol.</source><year>2002</year><volume>156</volume><issue>1</issue><fpage>137</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">11777936</pub-id></element-citation></ref><ref id="R65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aleku</surname><given-names>M</given-names></name><name><surname>Schulz</surname><given-names>P</given-names></name><name><surname>Keil</surname><given-names>O</given-names></name><name><surname>Santel</surname><given-names>A</given-names></name><name><surname>Schaeper</surname><given-names>U</given-names></name><name><surname>Dieckhoff</surname><given-names>B</given-names></name><name><surname>Janke</surname><given-names>O</given-names></name><name><surname>Endruschat</surname><given-names>J</given-names></name><name><surname>Durieux</surname><given-names>B</given-names></name><name><surname>Roder</surname><given-names>N</given-names></name><name><surname>Loffler</surname><given-names>K</given-names></name><name><surname>Lange</surname><given-names>C</given-names></name><name><surname>Fechtner</surname><given-names>M</given-names></name><name><surname>Mopert</surname><given-names>K</given-names></name><name><surname>Fisch</surname><given-names>G</given-names></name><name><surname>Dames</surname><given-names>S</given-names></name><name><surname>Arnold</surname><given-names>W</given-names></name><name><surname>Jochims</surname><given-names>K</given-names></name><name><surname>Giese</surname><given-names>K</given-names></name><name><surname>Wiedenmann</surname><given-names>B</given-names></name><name><surname>Scholz</surname><given-names>A</given-names></name><name><surname>Kaufmann</surname><given-names>J</given-names></name></person-group><article-title>Atu027 a liposomal small interfering RNA formulation targeting protein kinase N3 inhibits cancer progression.</article-title><source>Cancer Res.</source><year>2008</year><volume>68</volume><issue>23</issue><fpage>9788</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">19047158</pub-id></element-citation></ref><ref id="R66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santel</surname><given-names>A</given-names></name><name><surname>Aleku</surname><given-names>M</given-names></name><name><surname>Roder</surname><given-names>N</given-names></name><name><surname>Mopert</surname><given-names>K</given-names></name><name><surname>Durieux</surname><given-names>B</given-names></name><name><surname>Janke</surname><given-names>O</given-names></name><name><surname>Keil</surname><given-names>O</given-names></name><name><surname>Endruschat</surname><given-names>J</given-names></name><name><surname>Dames</surname><given-names>S</given-names></name><name><surname>Lange</surname><given-names>C</given-names></name><name><surname>Eisermann</surname><given-names>M</given-names></name><name><surname>Loffler</surname><given-names>K</given-names></name><name><surname>Fechtner</surname><given-names>M</given-names></name><name><surname>Fisch</surname><given-names>G</given-names></name><name><surname>Vank</surname><given-names>C</given-names></name><name><surname>Schaeper</surname><given-names>U</given-names></name><name><surname>Giese</surname><given-names>K</given-names></name><name><surname>Kaufmann</surname><given-names>J</given-names></name></person-group><article-title>Atu027 prevents pulmonary metastasis in experimental and spontaneous mouse metastasis models.</article-title><source>Clin Cancer Res.</source><year>2010</year><volume>16</volume><issue>22</issue><fpage>5469</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">21062934</pub-id></element-citation></ref><ref id="R67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williamson</surname><given-names>TL</given-names></name><name><surname>Cleveland</surname><given-names>DW</given-names></name></person-group><article-title>Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons.</article-title><source>Nat Neurosci.</source><year>1999</year><volume>2</volume><issue>1</issue><fpage>50</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">10195180</pub-id></element-citation></ref><ref id="R68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collard</surname><given-names>JF</given-names></name><name><surname>Cote</surname><given-names>F</given-names></name><name><surname>Julien</surname><given-names>JP</given-names></name></person-group><article-title>Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis.</article-title><source>Nature.</source><year>1995</year><volume>375</volume><issue>6526</issue><fpage>61</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">7536898</pub-id></element-citation></ref><ref id="R69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Tu</surname><given-names>P</given-names></name><name><surname>Abtahian</surname><given-names>F</given-names></name><name><surname>Trojanowski</surname><given-names>JQ</given-names></name><name><surname>Lee</surname><given-names>VM</given-names></name></person-group><article-title>Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation.</article-title><source>J. Cell Biol</source><year>1997</year><volume>139</volume><issue>5</issue><fpage>1307</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">9382875</pub-id></element-citation></ref><ref id="R70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thauerer</surname><given-names>B</given-names></name><name><surname>S. zur Nedden</surname><given-names>S</given-names></name><name><surname>Baier-Bitterlich</surname><given-names>G</given-names></name></person-group><article-title>Purine nucleosides: endogenous neuroprotectants in hypoxic brain.</article-title><source>J. Neurochem</source><year>2012</year><volume>121</volume><issue>3</issue><fpage>329</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">22335456</pub-id></element-citation></ref><ref id="R71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>zur Nedden</surname><given-names>S</given-names></name><name><surname>Tomaselli</surname><given-names>B</given-names></name><name><surname>Baier-Bitterlich</surname><given-names>G</given-names></name></person-group><article-title>HIF-1 alpha is an essential effector for purine nucleoside-mediated neuroprotection against hypoxia in PC12 cells and primary cerebellar granule neurons.</article-title><source>J. Neurochem</source><year>2008</year><volume>105</volume><issue>5</issue><fpage>1901</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">18248612</pub-id></element-citation></ref><ref id="R72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudolphi</surname><given-names>KA</given-names></name><name><surname>Schubert</surname><given-names>P</given-names></name><name><surname>Parkinson</surname><given-names>F</given-names></name><name><surname>Fredholm</surname><given-names>BB</given-names></name></person-group><article-title>Neuroprotective role of adenosine in cerebral ischaemia.</article-title><source>Trends Pharmacol. Sci</source><year>1992</year><volume>13</volume><issue>12</issue><fpage>439</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">1293870</pub-id></element-citation></ref><ref id="R73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sweeney</surname><given-names>MI</given-names></name></person-group><article-title>Neuroprotective effects of adenosine in cerebral ischemia: window of opportunity.</article-title><source>Neurosci. Biobehav. Rev</source><year>1997</year><volume>21</volume><issue>2</issue><fpage>207</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">9062944</pub-id></element-citation></ref><ref id="R74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Lubitz</surname><given-names>DK</given-names></name></person-group><article-title>Adenosine and cerebral ischemia: therapeutic future or death of a brave concept?.</article-title><source>Eur. J. Pharmacol</source><year>1999</year><volume>371</volume><issue>1</issue><fpage>85</fpage><lpage>102</lpage><pub-id pub-id-type="pmid">10355598</pub-id></element-citation></ref><ref id="R75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomaselli</surname><given-names>B</given-names></name><name><surname>Nedden</surname><given-names>SZ</given-names></name><name><surname>Podhraski</surname><given-names>V</given-names></name><name><surname>Baier-Bitterlich</surname><given-names>G</given-names></name></person-group><article-title>p42/44 MAPK is an essential effector for purine nucleoside-mediated neuroprotection of hypoxic PC12 cells and primary cerebellar granule neurons.</article-title><source>Mol. Cell. Neurosci</source><year>2008</year><volume>38</volume><issue>4</issue><fpage>559</fpage><lpage>68</lpage><pub-id pub-id-type="pmid">18585057</pub-id></element-citation></ref><ref id="R76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomaselli</surname><given-names>B</given-names></name><name><surname>Podhraski</surname><given-names>V</given-names></name><name><surname>Heftberger</surname><given-names>V</given-names></name><name><surname>B&#x000f6;ck</surname><given-names>G</given-names></name><name><surname>Baier-Bitterlich</surname><given-names>G</given-names></name></person-group><article-title>Purine nucleoside-mediated protection of chemical hypoxia-induced neuronal injuries involves p42/44 MAPK activation.</article-title><source>Neurochem. Int</source><year>2005</year><volume>46</volume><issue>7</issue><fpage>513</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">15843045</pub-id></element-citation></ref><ref id="R77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bocklinger</surname><given-names>K</given-names></name><name><surname>Tomaselli</surname><given-names>B</given-names></name><name><surname>Heftberger</surname><given-names>V</given-names></name><name><surname>Podhraski</surname><given-names>V</given-names></name><name><surname>Bandtlow</surname><given-names>C</given-names></name><name><surname>Baier-Bitterlich</surname><given-names>G</given-names></name></person-group><article-title>Purine nucleosides support the neurite outgrowth of primary rat cerebellar granule cells after hypoxia.</article-title><source>Eur. J. Cell Biol</source><year>2004</year><volume>83</volume><issue>2</issue><fpage>51</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">15146976</pub-id></element-citation></ref><ref id="R78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heftberger</surname><given-names>V</given-names></name><name><surname>Tomaselli</surname><given-names>B</given-names></name><name><surname>Podhraski</surname><given-names>V</given-names></name><name><surname>Baier-Bitterlich</surname><given-names>G</given-names></name></person-group><article-title>Purine Nucleoside Mediated Protection of Primary Cerebellar Granule Cells after Hypoxic Insult.</article-title><source>In: Foc. on Neurochem. Res. Nova Science Publ.</source><year>2005</year><fpage>1</fpage><lpage>19</lpage></element-citation></ref><ref id="R79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomaselli</surname><given-names>B</given-names></name><name><surname>Nedden</surname><given-names>SZ</given-names></name><name><surname>Podhraski</surname><given-names>V</given-names></name><name><surname>Baier-Bitterlich</surname><given-names>G</given-names></name></person-group><article-title>p42/44 MAPK is an essential effector for purine nucleoside-mediated neuroprotection of hypoxic PC12 cells and primary cerebellar granule neurons.</article-title><source>Mol. Cell. Neurosci</source><year>2008</year><volume>38</volume><issue>4</issue><fpage>559</fpage><lpage>68</lpage><pub-id pub-id-type="pmid">18585057</pub-id></element-citation></ref><ref id="R80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukai</surname><given-names>H</given-names></name><name><surname>Toshimori</surname><given-names>M</given-names></name><name><surname>Shibata</surname><given-names>H</given-names></name><name><surname>Takanaga</surname><given-names>H</given-names></name><name><surname>Kitagawa</surname><given-names>M</given-names></name><name><surname>Miyahara</surname><given-names>M</given-names></name><name><surname>Shimakawa</surname><given-names>M</given-names></name><name><surname>Ono</surname><given-names>Y</given-names></name></person-group><article-title>Interaction of PKN with alpha-actinin.</article-title><source>J. Biol. Chem</source><year>1997</year><volume>272</volume><issue>8</issue><fpage>4740</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">9030526</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Fig. (1)</label><caption><p>Structure of protein kinase C-related kinase (PKN).
</p></caption><graphic xlink:href="CN-12-213_F1"/></fig><fig id="F2" position="float"><label>Fig. (2)</label><caption><p>Key-role of PKN1 in neurotrophin-mediated rescue of hypoxic neuronal cells.
</p></caption><graphic xlink:href="CN-12-213_F2"/></fig></floats-group></article>